Overview of Intracoronary Brachytherapy for in-Stent Restenosis of a Drug-Eluting Stent

نویسندگان

  • Mohsen Mohammadi Medical Radiation Science Specialist, Department of Medical Radiation Science, School of Paramedicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Sohila Refahi Medical Physics Specialist, Department of Medical Physics, Faculty of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
چکیده مقاله:

Percutaneous coronary intervention with stenting is considered recently as the most common procedure for the treatment of symptomatic coronary. The article reviewed 41 studies published during 1997-2019 on intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent. Intracoronary radiation therapy was finally confirmed in the setting of in-stent restenosis using as adjunctive therapy. Irradiation dose to vessels may result in fibrosis, which can, in turn, cause the late formation of an aneurysm due to the weakness of the vessel wall. Intracoronary brachytherapy is a critical treatment which should not be ignored. 

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents

PURPOSE Given the limited salvage options for in-stent restenosis (ISR) of drug-eluting stents (DES), our high-volume cardiac catheterization laboratory has been performing intracoronary brachytherapy (ICBT) in patients with recurrent ISR of DES. This study analyzes their baseline characteristics and assesses the safety/toxicity of ICBT in this high-risk population. METHODS AND MATERIALS A re...

متن کامل

Drug-Eluting Stent Restenosis

OBJECTIVES We sought to determine if the angiographic pattern of in-stent restenosis in drug-eluting stents (DES) maintains its prognostic importance. BACKGROUND The pattern of restenosis in the bare-metal stent era had a significant impact on therapeutic outcomes. METHODS We identified a total of 250 consecutive restenotic lesions in 203 patients (66.4% sirolimuseluting stents and 33.6% paclit...

متن کامل

Intracoronary brachytherapy for the treatment of complex in-stent restenosis.

T he development of an effective strategy for management of in-stent restenosis (ISRS) following ‘‘bare metal’’ stenting has proved difficult. Standard percutaneous therapy for ISRS leads to re-restenosis rates above 50% and consequently represents a poor treatment option. At present the ‘‘gold standard’’ treatment for ISRS is vascular brachytherapy (VBT), with re-restenosis rates falling to be...

متن کامل

Drug-eluting stent restenosis rates?

The article by Lemos et al1 describing coronary restenosis after implantation of sirolimus-eluting stents is of great interest. With the increasing demand for drug-eluting stents (DES) and the recent formation of guidelines for their use, confirmation of their continued efficacy in reducing restenosis is important. Therefore, registry data from a large patient population such as the Thoraxcente...

متن کامل

Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.

Drug-eluting stents (DESs), although promising technology, still are associated with restenosis; therefore, we evaluated the safety and efficacy of intravascular radiation therapy for the treatment of DES in-stent restenosis (ISR). Treatment of DES ISR has not been established, although intravascular radiation therapy is an effective treatment for patients with ISR of bare metal stents. Other m...

متن کامل

In-stent restenosis in the drug-eluting stent era.

The introduction of the drug-eluting stent (DES) proved to be an important step forward in reducing rates of restenosis and target lesion revascularization after percutaneous coronary intervention. However, the rapid implementation of DES in standard practice and expansion of the indications for percutaneous coronary intervention to high-risk patients and complex lesions also introduced a new p...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


عنوان ژورنال

دوره 7  شماره 1

صفحات  400- 405

تاریخ انتشار 2019-03-01

با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023